Videos

Video of ASNC President Mouaz Al-Mallah, MD, explaining some long-COVID cardiac symptoms might be due to coronary microvascular dysfunction. He was part of a recent study that used PET top assess myocardial perfusion that found there is impaired microvascular flow in long-COVID patients.

PET imaging helps assess coronary microvascular dysfunction in long COVID patients

Researchers noted that patients appeared to have myocarditis at first, but a closer examination revealed it was something else entirely. 

Esteban Rubens, Oracle cloud field chief technology officer for healthcare, explains cloud’s role in enterprise imaging and healthcare IT and the movement away from on-premise data storage.

More and more hospitals are using the cloud for medical image storage

Cloud data storage is growing in medical imaging as a way of simplifying workflows and providing relief to health IT teams, Esteban Rubens explained in an interview. 

Video interview with Martha Gulati, MD, was the lead author of the 2021 chest pain guidelines and shares impacts.

Cardiac CT gaining popularity due to chest pain guidelines, cost savings

Cardiologist Martha Gulati, MD, lead author of the 2021 chest pain guidelines, explained how the document may have contributed to the rise of cardiac CT. "These guidelines have made it harder for people to push back and say you don't need this test," she said. 

Video interview with ASNC President President Mouaz Al-Mallah, MD, who explains why nuclear cardiology needs to upgrade its technology to be competitive. #ASNC #ASNC2023 #ASNC23

Previewing ASNC 2023: Why nuclear cardiology needs to evolve

ASNC President President Mouaz Al-Mallah, MD, said nuclear cardiology needs to upgrade old imaging systems and embrace new technology to deliver better value for patients. 

Ritu Thamman, MD, FASE, University of Pittsburgh School of Medicine, discusses trends and the technical aspects of strain imaging. #ASE #ASE23 #ASE2023 #strainecho

Strain imaging making a significant impact on the treatment of heart patients

Strain imaging has gained considerable momentum in recent years as an effective tool for getting more value out of heart evaluations. Ritu Thamman, MD, provided an in-depth look at the latest trends in strain echocardiography in an exclusive interview. 

Video of Denise Garris, ASE regulatory consultant and principal of the Korris Group, explaining how reimbursements from insurance andMedicare work to pay or cardiac ultrasound exams. #ASE #ASE360 #ASE23 #ASE2023 #healthcarereimbursment

Understanding reimbursements and coding for echocardiography

"I think everyone would agree that the current fee-for-service model is not working appropriately and there needs to be a fix," regulatory consultant Denise Garris explained in a new interview. 

Jackie Sohn, DO, explains the use and trating requirements for intensivists and anesthesiologists to train on using point of care ultrasound (POCUS) at ASE 2023.

Training noncardiologists to perform basic POCUS exams

Jackie Sohn, DO, discussed how POCUS is now incorporated into fellowship training programs and the different ways these handheld and smaller cart-based systems are being utilized in hospitals.

Purvi Parwani, MD, director of echocardiography, Loma Linda University Medical Center, explains the trend where heart failure imaging guidelines are driving a rising use of mixed multimodality imaging. #ASE #ASE2023

Multimodality imaging helps cardiologists manage heart failure patients—with an assist from AI

Purvi Parwani, MD, discussed the trend toward multimodality imaging for heart failure management. All modalities have their own weaknesses, she explained. 

Around the web

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Trimed Popup
Trimed Popup